SOURCE: Analyst Choice

Analyst Choice

December 23, 2009 06:49 ET

Analyst Choice Initiates Research on Equities Within Healthcare and Technology Sectors

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Analyst Choice

NEW DELHI, INDIA--(Marketwire - December 23, 2009) - U.S. stocks rose on Monday, with the NASDAQ hitting a 15-month high after a healthcare reform bill advanced in the Senate and brokerages upgraded two Dow components on improving profit prospects. This drove us to do research on the following 6 stocks Hemispherx Biopharma Inc. (AMEX: HEB), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Celgene Corporation (NASDAQ: CELG), Automatic Data Processing Inc. (NASDAQ: ADP), Verizon Communications Inc. (NYSE: VZ) and EMC Corporation (NYSE: EMC). You can now access these research reports with many others by signing up at Analyst Choice.

To see if our analysts believe you should BUY, SELL or HOLD these six stocks click on the link below

The following are exempts of the above reports:

--  HEB is making continuous discussions with its Japanese collaborative
    partners regarding proposed means to enhance the effectiveness of vaccines
--  Drawing from years of real-world testing and experience, ARNA have
    tailored its global biotech solutions to help consumer and manufacturers
    speed time-to-market and do it with less risk, and...
--  CELG entered in to a definitive merger agreement with Gloucester
    Pharmaceuticals Inc., under which Celgene Corporation will acquire
    Gloucester Pharmaceuticals.
--  ADP entered in to a strategic partnership with BackCheck, a division
    of Checkwell - one of the world's leading providers of employment screening
--  VZ has invested more than $45 billion nationwide since it was formed
    -- $5.5 billion on average every year...
--  Although EMC has experienced a considerable drop in the value from
    $18.44 level to $9.61 in last one year, but...

You can now access these full research reports along with many others by signing up for free at Analyst Choice or

About Analyst Choice:

Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. While the world economy undergoes enormous pressure and unprecedented actions are been taken to avoid the worst and boost the shrinking global economic growth, our analysts brings you a bird's eye view of how the big players in the different key sectors and industries of the NASDAQ and NYSE, are coping. Sign up now by visiting the following link. is an independent financial research portal and as such has not received any compensation by any of the above mentioned companies.